Serum magnesium and lipids: More clarity is needed

Atherosclerosis

Volumn 192, Issue 1, 2007, Pages 233-234

  Corsonello, Andrea ^a   Perticone, Francesco ^b   Ientile, Riccardo ^c   Barbagallo, Mario ^d   Corica, Francesco ^c  

^a INRCA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Diabetes; Lipids; Magnesium; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LETTER; MAGNESIUM BLOOD LEVEL; METABOLIC DISORDER; OBESITY; POPULATION; PRIORITY JOURNAL;

ADULT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; HUMANS; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 34247136332     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.02.014     Document Type: Letter

References (15)

1. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2006; doi:10.1016/j.atherosclerosis.2006.11.024.
2. Corica F., Corsonello A., Buemi M., et al. Platelet magnesium depletion in normotensive and hypertensive obese subjects: the role of salt-regulating hormones and catecholamines. Magnes Res 12 (1999) 287-296
3. Corica F., Allegra A., Ientile R., et al. Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test. Am J Hypertens 12 2 Pt 1 (1999) 128-136
4. Durlach J., and Rayssiguier Y. Magnésium et glucides, II. Données cliniques et thérapeutiques. Magnesium 2 (1983) 192-224
5. Resnick L.M., Gupta R.K., Bhargava K.K., et al. Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension 17 (1991) 951-957
6. Resnick L.M. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders: mechanism of syndrome X. Am J Hypertens 6 (1993) 123S-134S
7. Paolisso G., and Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 10 (1997) 346-355
8. Corica F., Corsonello A., Ientile R., et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25 (2006) 210-215
9. Corsonello A., Ientile R., Buemi M., et al. Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol 20 (2000) 187-192
10. Haenni A., Ohrvall M., and Lithell H. Atherogenic li pid fractions are related to ionized magnesium status. Am J Clin Nutr 67 (1998) 202-207
11. Resnick L.M., Altura B.T., Gupta R.K., et al. Intracellular and extracellular magnesium depletion in type II (non insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 767-770
12. Barbagallo M., Gupta R., Dominguez L.J., and Resnick L.M. Cellular ionic alterations with aging: relation to hypertension and diabetes. J Am Geriatr Soc 48 (2000) 1111-1116
13. Robles N.R., Escola J.M., Albarran L., and Espada R. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Nephron 78 (1998) 118-119
14. Bastida S., Vaquero M.P., Veldhuizen M., and Sanchez-Muniz F.J. Selected trace elements and minerals in cord blood: association with lipids and lipoproteins at birth. Acta Paediatr 89 (2000) 1201-1206
15. Nozue T., Kobayashi A., Uemasu F., et al. Magnesium status, serum HDL cholesterol, and apolipoprotein A-1 levels. J Pediatr Gastroenterol Nutr 20 (1995) 316-318